+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

InspireMD Inc (NSPR) - Product Pipeline Analysis, 2020 Update

  • ID: 4372875
  • Company Profile
  • January 2021
  • 39 pages
  • GlobalData

FEATURED COMPANIES

  • Bioiasis AD Sofia
  • Etropal Ad
  • InterCure Ltd
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, acute myocardial infarction, and saphenous vein graft coronary intervention. It utilizes MicroNet stent platform technology to develop its products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company InspireMD Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bioiasis AD Sofia
  • Etropal Ad
  • InterCure Ltd
  • MORE
InspireMD Inc Company Overview
  • InspireMD Inc Company Snapshot
  • InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc - Pipeline Analysis Overview

InspireMD Inc - Key Facts

InspireMD Inc - Major Products and Services

InspireMD Inc Pipeline Products by Development Stage
  • InspireMD Inc Ongoing Clinical Trials by Trial Status
  • InspireMD Inc Pipeline Products Overview
  • CGuard Embolic Prevention System
  • CGuard Embolic Prevention System Product Overview
  • CGuard Embolic Prevention System Clinical Trial
  • MGuard Drug Eluting Stent
  • MGuard Drug Eluting Stent Product Overview
  • Next Gen CGuard - 5F
  • Next Gen CGuard - 5F Product Overview
  • NGuard
  • NGuard Product Overview
  • PVGuard Peripheral
  • PVGuard Peripheral Product Overview
  • RGuard Renal
  • RGuard Renal Product Overview
InspireMD Inc - Key Competitors

InspireMD Inc - Key Employees

InspireMD Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • InspireMD Inc, Recent Developments
  • Mar 10, 2020: InspireMD announces fourth quarter and year-end 2019 financial results
  • Jan 29, 2020: InspireMD announces successful live clinical case transmissions featuring CGuard EPS at the Leipzig Interventional Course (LINC) 2020
  • Jan 27, 2020: InspireMD’s CGuard Embolic Prevention System to be prominently featured in live case transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany
  • Jan 06, 2020: InspireMD announces strong preliminary fourth quarter 2019 revenue and reports inducement award under NYSE American Company Guide §711(a)
  • Dec 10, 2019: InspireMD announces planned leadership transition
  • Dec 10, 2019: InspireMD announces planned leadership transition
  • Nov 26, 2019: InspireMD reports updated positive CGuard EPS data presented at VEITH 2019
  • Nov 12, 2019: InspireMD announces third quarter 2019 financial results
  • Sep 09, 2019: InspireMD provides business update
  • Aug 06, 2019: InspireMD announces second quarter 2019 financial results
Appendix
  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
  • InspireMD Inc Pipeline Products by Equipment Type
  • InspireMD Inc Pipeline Products by Indication
  • InspireMD Inc Ongoing Clinical Trials by Trial Status
  • InspireMD Inc, Key Facts
  • InspireMD Inc, Major Products and Services
  • InspireMD Inc Number of Pipeline Products by Development Stage
  • InspireMD Inc Pipeline Products Summary by Development Stage
  • InspireMD Inc Ongoing Clinical Trials by Trial Status
  • InspireMD Inc Ongoing Clinical Trials Summary
  • CGuard Embolic Prevention System - Product Status
  • CGuard Embolic Prevention System - Product Description
  • CGuard Embolic Prevention System - A Multicenter Italian Registry of Real World CAS with C-Guard Mesh Covered Stent: The IRONGUARD 2 Study
  • CGuard Embolic Prevention System - A Pivotal Study of the CGuard Carotid Stent System CARENET-III for Prevention of Stroke in Patients in the United States.
  • CGuard Embolic Prevention System - Carotid Artery Revascularization Using TransCarotid flow Reversal Cerebral Protection And CGUARD MicroNET-covered Embolic Prevention Stent System to Reduce Strokes in Patients with Symptoms or Signs of Cerebral Ischemia: TOP-GUARD Study
  • CGuard Embolic Prevention System - Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent (Acculink) Versus the Mesh Covered Stent (CGuard): The SIBERIA Trial
  • CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
  • CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
  • CGuard Embolic Prevention System - Prospective Evaluation of All-comer Percutaneous Carotid Revascularization In Symptomatic and Increased-risk Asymptomatic Carotid Artery Stenosis
  • CGuard Embolic Prevention System - Prospective Observational Study of CGuard MicroNet Covered Stent System Use as a Flow Diverter in the Endovascular Exclusion of Carotid Artery Aneurysms. (CGuard Divert-and-HEAL C-HEAL)
  • CGuard Embolic Prevention System - Prospective Observational Study of Procedures with MicroNet Covered Stent Use to Treat Increased Risk Lesions in Arterial Locations Beyond the Carotid Bifurcation - FLOW-Guard Study
  • MGuard Drug Eluting Stent - Product Status
  • MGuard Drug Eluting Stent - Product Description
  • Next Gen CGuard - 5F - Product Status
  • Next Gen CGuard - 5F - Product Description
  • NGuard - Product Status
  • NGuard - Product Description
  • PVGuard Peripheral - Product Status
  • PVGuard Peripheral - Product Description
  • RGuard Renal - Product Status
  • RGuard Renal - Product Description
  • InspireMD Inc, Key Employees
  • InspireMD Inc, Other Locations
  • InspireMD Inc, Subsidiaries
  • Glossary
List of Figures
  • InspireMD Inc Pipeline Products by Equipment Type
  • InspireMD Inc Pipeline Products by Development Stage
  • InspireMD Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • InterCure Ltd
  • Etropal Ad
  • Bioiasis AD Sofia
Note: Product cover images may vary from those shown
Adroll
adroll